Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Ireland to legalise cannabis for medicinal purposes

Report from the Health Products Regulatory Authority 'cautiously' advises restricted use of the drug 

Friday 10 February 2017 19:49 GMT
Comments
Under new proposals, the government would collect tax on the drug
Under new proposals, the government would collect tax on the drug

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Cannabis is set to be legalised for the treatment of several medical conditions in Ireland.

A new scheme will see the drug used to treat patients with epilepsy, intractable nausea and other illnesses. Running for five years, it will be monitored by health service experts.

A report by Ireland's Health Products Regulatory Authority (HPRA) warned of the lack of evidence over Cannabis' effectiveness and safety,

But Simon Harris, the country's Minister for Health has given the go ahead for the drug to be used.

“I believe this report marks a significant milestone in developing policy in this area,” Mr Harris told The Guardian. “This is something I am eager to progress but I am also obligated to proceed on the basis of the best clinical advice.”

Professor Tony O’Brien, chairman of the HRPA, said he was pleased to “cautiously advise” for the restricted use of cannabis products for a small number of medical conditions.

“Access to medicinal cannabis is ultimately a societal and policy decision which has to balance the lack of scientific evidence against patient-led demand,” the report said, according to The Irish Times.

It did however note there was “insufficient information” about the long-term safety of cannabis usage.

“The scientific evidence supporting the effectiveness of cannabis across a large range of medical conditions is in general poor, and often conflicting,” it said. “Cannabis has potential therapeutic benefits but these need to be better defined through clinical research.”

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in